Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2012
08/23/2012WO2012112841A2 [1,2,4]oxadiazol-3-yl acid salts and crystalline forms and their preparation
08/23/2012WO2012111997A2 Cell therapy composition for preventing or treating immune disease comprising mesenchymal stem cells and immunoregulatory t-cells as active ingredient
08/23/2012WO2012111834A1 Hydrogen-emitting composition
08/23/2012WO2012111187A1 Skin collagen production promoter
08/23/2012WO2012110968A2 Treatment of fistulizing crohn's disease
08/23/2012WO2012110360A1 Antibody against the csf-1r
08/23/2012WO2012110200A1 Cyclic peptide cyclo (l -arginyl - glycyl - l -aspartyl - d - phenylalanyl - n-methyl - l -valyl), compositions thereof, and use thereof in methods for treating graft -versus - host disease
08/23/2012WO2012026712A4 Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing stem cells treated with nod2 agonist or cultured product thereof
08/23/2012WO2012006384A9 Rothia species gluten-degrading enzymes and uses thereof
08/23/2012US20120214869 Novel ligand activators of the rar receptors and pharmaceutical/cosmetic applications thereof
08/23/2012US20120214866 Treatment with cytokines
08/23/2012US20120214858 Imidamide sphingosine kinase inhibitors
08/23/2012US20120214854 Carboxy oxazole or thiazole compounds as dgat- 1 inhibitors useful for the treatment of obesity
08/23/2012US20120214848 [1,2,4]oxadiazol-3-yl acid salts and crystalline forms and their preparation
08/23/2012US20120214847 2-[1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
08/23/2012US20120214846 Hexahydrocyclopentyl[f]indazole pyridyl ethanols and derivatives thereof as selective glucocorticoid receptor modulators
08/23/2012US20120214841 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
08/23/2012US20120214834 Immune enhancement composition and kit and use thereof
08/23/2012US20120214826 Inhibitors of bruton's tyrosine kinase
08/23/2012US20120214814 Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modifications at c-17
08/23/2012US20120214806 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines
08/23/2012US20120214801 Compositions and methods relating to novel compounds and targets thereof
08/23/2012US20120214800 Organic Compounds
08/23/2012US20120214794 Heteroaryls and uses thereof
08/23/2012US20120214792 Thieno- adn furo-pyrimidine modulators of the histamine h4 receptor
08/23/2012US20120214787 Oxadiazole inhibitors of leukotriene production
08/23/2012US20120214775 Pharmaceutical Salts of 3-O-(3',3'-Dimethylsuccinyl) Betulinic Acid
08/23/2012US20120214767 Tricyclic heterocyclic compounds
08/23/2012US20120214762 6,5-heterocyclic propargylic alcohol compounds and uses therefor
08/23/2012US20120214745 Deuterated Cyclosporine Analogs and Methods of Making the Same
08/23/2012US20120214741 Vdac1 compositions and methods of use thereof for regulating apoptosis
08/23/2012US20120214732 Inhibitors of the Trypsin-Like Site of the Proteasome and Methods of Use Thereof
08/23/2012US20120214729 Composition for preventing or treating inflammation
08/23/2012US20120214687 Baff receptor (bcma), an immunoregulatory agent
08/23/2012US20120214206 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
08/23/2012US20120213872 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
08/23/2012US20120213862 Negative Ion-Releasing Silica Compositions and Methods of Preparing and Using the Same
08/23/2012US20120213854 Methods of treating a subject and related particles, polymers and compositions
08/23/2012US20120213848 Treatment of Infection Using Single Chain Antibody Gene Therapy
08/23/2012US20120213840 Ocular strips
08/23/2012US20120213833 Prevotella histicola preparations and the treatment of autoimmune conditions
08/23/2012US20120213829 Dry powder aerosols of nanoparticulate drugs
08/23/2012US20120213824 Use of pufas for treating skin inflammation
08/23/2012US20120213823 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
08/23/2012US20120213820 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection
08/23/2012US20120213819 Hemagglutinin polypeptides, and reagents and methods relating thereto
08/23/2012US20120213818 Combination therapy for immunostimulation
08/23/2012US20120213816 Mycoplasma hyopneumoniae bacterin vaccine
08/23/2012US20120213815 Vaccines and immunotherapeutics using codon-optimized il-15 and methods for using the same
08/23/2012US20120213814 Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes
08/23/2012US20120213813 Alphavirus replicon particles as immunological adjuvants
08/23/2012US20120213811 Chimeric hiv fusion proteins as vaccines
08/23/2012US20120213810 Novel european prrsv strain
08/23/2012US20120213809 Vault complexes for cytokine delivery
08/23/2012US20120213808 Carbonic anhydrase i serving as novel antigen to be used for treatment of autoimmune diseases
08/23/2012US20120213803 Methods for diagnosing and treating encephalitis or epilepsy
08/23/2012US20120213799 Compositions and methods for treating inflammatory disorders
08/23/2012US20120213795 Compositions and methods for inhibition of the jak pathway
08/23/2012US20120213792 Human antibodies that bind human il-12 and methods for producing
08/23/2012US20120213791 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
08/23/2012US20120213777 Vascular endothelial growth factor 2
08/23/2012US20120213773 Binding domain-immunoglobulin fusion proteins
08/23/2012US20120213771 Antibodies that bind human cd27 and uses thereof
08/23/2012US20120213768 Diagnostic and Therapeutic Uses for B Cell Maturation Antigen
08/23/2012US20120213747 Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells
08/23/2012US20120213731 Methods and compositions for treating autoimmune diseases
08/23/2012US20120213730 Alteration of cell membrane for new functions
08/23/2012US20120213707 Riboflavin Based Aerosol and Use as Placebo in Trials
08/23/2012US20120213699 Single chain fragment of monoclonal antibody 9b9 and uses thereof
08/23/2012DE102010055585A1 Nanoparticles useful for treating rheumatic diseases comprises amorphous ferrosilicon exhibiting magnetizable properties
08/23/2012CA2826543A1 Treatment of fistulizing crohn's disease
08/23/2012CA2825243A1 Antibody against the csf-1r
08/22/2012EP2489729A2 Apoptotic cell-mediated transfection of mammalian cells with interfering RNA
08/22/2012EP2489663A1 Compounds as syk kinase inhibitors
08/22/2012EP2489658A1 3-Heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
08/22/2012EP2489368A1 Minor allergen control to increase safety of immunotherapy
08/22/2012EP2489361A1 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
08/22/2012EP2488524A1 Pyrrolo[2,3-d]pyrimidine compounds
08/22/2012EP2488523A1 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
08/22/2012EP2488511A1 Pyrazole inhibitors of phosphatidylinositol 3-kinase
08/22/2012EP2488486A1 Hematopoietic growth factor mimetic small molecule compounds and their uses
08/22/2012EP2041117B1 Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity
08/22/2012EP1507780B1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
08/22/2012CN1997741B Novel mite allergen
08/22/2012CN1909918B T cell immunoreaction inhibitor
08/22/2012CN1767839B Antiallergic composition
08/22/2012CN1622815B Immune stimulating substance including methane nutrition bacteria biomass
08/22/2012CN1449825B Method for inactivating Bordetella bronchiseptica culture, bacteria composition prepared by same and vaccine having same and use thereof
08/22/2012CN1449293B Multivalent vaccine composition
08/22/2012CN1441676B Method of treatment using ligand-immunogen conjugates
08/22/2012CN102648201A N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
08/22/2012CN102648198A Pyridine derivatives as S1P1/EDG1 receptor modulators
08/22/2012CN102648183A Substituted pyrazoles as estrogen receptor ligands
08/22/2012CN102643783A Preparation method of activated mononuclear cell for cell immunotherapy
08/22/2012CN102643361A Nano selenium micromolecular microbial polysaccharide as well as preparation method and application thereof
08/22/2012CN102643360A Extraction and separation method of natto polysaccharide
08/22/2012CN102643359A Hericium erinaceus polysaccharide and preparation method thereof
08/22/2012CN102643344A Binding constructs and methods for use thereof
08/22/2012CN102643316A Acylated glycoside compounds as well as production method and application thereof
08/22/2012CN102643255A Andrographolide compound
1 ... 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 ... 1172